Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons.
about
Pharmacotherapies for sleep disturbances in Alzheimer's diseaseLight therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementiaLight therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementiaMelatonin, immune function and agingNeurotransmitters of the suprachiasmatic nuclei.Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review)Melatonin in Alzheimer's disease and other neurodegenerative disordersCircadian rhythms and sleep in human aging.The circadian clock and pathology of the ageing brain.Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease.Sleep disturbances in Alzheimer's and Parkinson's diseases.Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Sleep in older adults: normative changes, sleep disorders, and treatment options.Melatonin Therapy in Patients with Alzheimer's Disease.Therapeutic application of melatonin in mild cognitive impairment.Melatonin: buffering the immune systemMicrotubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.Pharmacotherapies for sleep disturbances in dementia.Clinical aspects of melatonin intervention in Alzheimer's disease progressionActigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer's disease.Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study.Role of melatonin combined with exercise as a switch-like regulator for circadian behavior in advanced osteoarthritic knee.Sleep Disturbance, Cognitive Decline, and Dementia: A Review.Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer's type dementia: a case series.Sleep disturbances among nursing home residents.Improved cognitive morning performance in healthy older adults following blue-enriched light exposure on the previous evening.
P2860
Q24197895-17BC23F6-2D66-4D06-912A-624381613BE7Q24200245-44BF61FA-72AD-453F-96FF-8B20322B5361Q24240271-7171DBE6-7911-43D2-8176-F823314B7160Q25255508-5653AE9E-E46D-4FED-85C0-D8F30C67D1F1Q25257183-651875EF-4CF2-4848-9A4A-43BF3CF8884EQ28079228-19258238-85A1-41D3-A677-16AB827D35D7Q28217483-8235BEC7-E0DE-474D-83E7-77217393B375Q33936300-765C4596-AB30-408B-8FD6-AD462EE38D49Q34259247-2CF6D02C-1281-4C69-81B8-0F4A8D06F6DDQ34416921-9095C781-4BB2-4968-8993-9CDA19864DF7Q35216142-92C798C7-7680-4F9E-9F6F-4E94BF12773BQ35981780-579FB317-EEE3-40CB-9BA3-546E1E45B462Q36040915-66156119-A99A-4F4C-AB50-5A82B2077B0EQ36307859-4FF15E42-7A46-497D-82CF-196C790FD171Q36335048-C19AC978-B4DC-4176-85E4-DDEDB163220DQ36576496-CB4AD4CC-8C41-4383-8C5E-D19ADF00511BQ36820644-EC564553-B1D1-4812-8F45-B54AD46B29BEQ37253704-40A18EE9-BAC6-4BFD-A095-D7FC32ADA159Q38022179-BEC7140E-9478-466D-9E37-074A6B686ECCQ39010202-FE3681D4-F249-437D-9A3C-93F6216628F5Q41136734-152A8A6A-E66A-4880-B51D-764D353E41B7Q43689408-AB53A1F3-0BBD-4A01-AE63-AE62DBADD465Q46970981-390EE4F1-61F3-46B8-860C-6AE8877599D9Q47102304-1DDC242B-9BB3-44FA-8B86-852B43F64AB6Q47637646-B3496AAE-4CFA-4D28-9DEB-3C33F067DE2FQ47770202-D23D9416-5A2F-4E03-A1F0-9C3F33C7FA56Q48656634-DA02C32B-AB75-435F-8F6B-D9AF33D9010FQ52804479-12BAB6FA-C5E0-4510-86D0-CB42099BEE2A
P2860
Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Supplementary administration o ...... ized demented elderly persons.
@ast
Supplementary administration o ...... ized demented elderly persons.
@en
type
label
Supplementary administration o ...... ized demented elderly persons.
@ast
Supplementary administration o ...... ized demented elderly persons.
@en
prefLabel
Supplementary administration o ...... ized demented elderly persons.
@ast
Supplementary administration o ...... ized demented elderly persons.
@en
P2093
P2860
P356
P1476
Supplementary administration o ...... ized demented elderly persons.
@en
P2093
P2860
P304
P356
10.1081/CBI-100101055
P407
P577
2000-05-01T00:00:00Z